Luigi Bernardi

This inventor holds 54 USPTO granted patents, primarily in Ergoline Derivatives (CPC class 2603). Top assignees: Societa' Farmaceutici Italia, Farmitalia Carlo Erba, Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 1976-1998.

USPTO Granted Patents = 54

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 11

Forward Citations = 594(Granted Patents)

Forward Citations (Not Self Cited) = 565(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Milan MI, IT (1995)
Milan, IT (1976 - 1998)

Company Filing History:

22 out of 48

Societa' Farmaceutici Italia

patents

19 out of 208

Farmitalia Carlo Erba

patents

11 out of 343

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

Farmitalia Societa Farmaceutica Italia

patent

Years Active: 1976-1998

Loading Chart...

Areas of Expertise:

Ergoline Compounds

Anti-Parkinson Agents

Anthracycline Derivatives

Neuroleptic Activity

Hydrazono Derivatives

Wearable Pancreas

Cardenolides

Pyrazine Inhibitors

Daunomycin Aglycones

Pyridazinyl Compounds

Therapeutic Compositions

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5721227 - 17-aryl and 17-heterocyclyl-14.beta.-5.alpha.-androstane, androstene and (1998-02-24),

2. 5593982 - Cyclopentanperhydrophenanthren-17.beta.-(3-furyl)-3-derivatives and (1997-01-14),

3. 5591734 - 17-(3-furyl)-5.beta., 14.beta.-androstane derivatives active on the (1997-01-07),

4. 5567697 - 17-(4-pyridazinyl) -5.beta., 14.beta.-androstane derivatives active on (1996-10-22),

5. 5567694 - 17-Aryl and 17-heterocyclyl-5.beta.,14.beta.-androstane derivatives (1996-10-22),

6. 5556846 - 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene (1996-09-17),

7. 5538960 - Hydrazono-5.beta., 14.beta.-androstane derivatives active on the (1996-07-23),

8. 5489582 - 14-deoxy-14.alpha.-cardenolides 3.beta.-thioderivatives and (1996-02-06),

9. 5478817 - Digitoxigenin and dihydrodigitoxigenin 3.beta.-derivatives and (1995-12-26),

10. 5444055 - 17-hydroxyiminomethyl-5-.beta., 14 .beta.-androstane derivatives active (1995-08-22),

11. 5432169 - Cyclopentanperhydrophenanthren-17.beta.-(3-furyl)-3-derivatives and (1995-07-11),

12. 5298022 - Wearable artificial pancreas (1994-03-29),

13. 4861793 - D-nor-7-ergoline derivatives having anti-Parkinson and antipsychosis (1989-08-29),

14. 4746666 - Ergoline compounds useful as antiparkinson agents (1988-05-24),

15. 4690929 - Ergolines exhibiting protactin secretion inhibition activity (1987-09-01),

Title: Luigi Bernardi - Innovative Mind from Milan

Introduction: Luigi Bernardi, a distinguished inventor hailing from Milan, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Luigi Bernardi's recent patents include cutting-edge advancements in renewable energy systems, artificial intelligence algorithms, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Luigi Bernardi has established himself as a visionary in the realm of technological innovation. His work has revolutionized various industries, from healthcare to telecommunications.

Collaborations: Throughout his career, Luigi Bernardi has collaborated with leading research institutions, universities, and multinational corporations to bring his inventive ideas to life. His partnerships have resulted in the development of pioneering technologies that have had a lasting impact on society.

Conclusion: Luigi Bernardi's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a trailblazer in the world of inventions. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancement.